Evolution of hypertrophic cardiomyopathy to a contemporary treatable disease

Circulation

Volumn 126, Issue 13, 2012, Pages 1640-1644

  Maron, Barry J ^a   Braunwald, Eugene ^b  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CLINICAL EFFECTIVENESS; DEFIBRILLATOR; FAMILY HISTORY; FEMALE; HEART FAILURE; HEART OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MUSCLE RESECTION; PRIMARY PREVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; RISK REDUCTION; SINUS RHYTHM; STROKE; SUDDEN DEATH;

CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN; DEFIBRILLATORS, IMPLANTABLE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FIBRILLATION; VENTRICULAR SEPTUM;

EID: 84866639676     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.123174     Document Type: Article

References (34)

1. Maron BJ, Spirito P, Shen W-K, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NAM 3rd, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P. Implantable cardioverterdefibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298:405-412. (Pubitemid 47124061)
2. Braunwald E, Lambrew CT, Rockoff SD, Ross J Jr, Morrow AG. Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation. 1964;30:3-119.
3. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958;20:1-8.
4. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2003;42:1687-1713.
5. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rawkowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. 2011 ACCF/AHA guidelines for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:e783-e831.
6. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rawkowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA Guidelines for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;5:e212-e260.
7. American College of Cardiology Foundation/American Heart Association Task Force on Practice; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons, Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guidelines for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2011;142:e153-e203.
8. Maron BJ, Gardin JM, Flack JM, Gidding SS, Bild D. Assessment of the prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation. 1995;92:785-789.
9. Maron BJ, Maron MS, Wigle ED, Braunwald E. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: From idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009;54:191-200.
10. Maron BJ, Braunwald E. Eugene Braunwald MD and the early years of hypertrophic cardiomyopathy: A conversation with Dr. Barry J. Maron. Am J Cardiol. 2012;109:1539-1547.
11. Maron BJ, Seidman CE, Ackerman MJ, Towbin JA, Maron MS, Ommen SR, Nishimura RA, Gersh BJ. What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy. Circ Cardiovasc Genet. 2009;2:81-86.
12. Morrow AG, Braunwald E. Functional aortic stenosis: A malformation characterized by resistance to left ventricular outflow without anatomic obstruction. Circulation. 1959;20:181-189.
13. Harrison DC, Braunwald E, Glick G, Mason DT, Chidsey CA, Ross J Jr. Effects of betaadrenergic blockade on the circulation with particular reference to observations in patients with hypertrophic subaortic stenosis. Circulation. 1964;29:84-98.
14. Cohen LS, Braunwald E. Amelioration of angina pectoris in idiopathic hypertrophic subaortic stenosis with beta-adrenergic blockade. Circulation. 1967;35:847-851.
15. Morrow AG, Brockenbrough EC. Surgical treatment of idiopathic hypertrophic subaortic stenosis. Ann Surg. 1961;154:181-189.
16. Maron BJ. Sudden death in young athletes. N Engl J Med. 2003;349:1064-1075. (Pubitemid 37098275)
17. Maron BJ, Casey SA, Haas TS, Kitner C, Garberich R. Hypertrophic cardiomyopathy with longevity to 90 years of older. Am J Cardiol. 2012;9:1341-1347.
18. Maron MS, Rowin E, Casey S, Haas T, Appelbaum E, Garberich R, Maron BJ. Risk stratification and outcome of patients with hypertrophic cardiomyopathy over 60 years of age: Does age count? Circulation. 2011; 124:A14156. Abstract.
19. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348:295-303. (Pubitemid 36119984)
20. Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, Gersh BJ, Ackerman MJ, McCully RB, Dearani JA, Schaff HV, Danielson GK, Tajik AJ, Nishimura RA. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46:470-476. (Pubitemid 41040288)
21. Maron BJ. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation. 2010;121:445-456.
22. Chan RH, Maron B, Olivotta I, Assenza G, Hong MS, Lesser J, Haas T, Gruner C, Crean A, Rakowski H, Udelson J, Rowin E, Tomberli B, Spirito P, Formisano F, Biagini E, Rapezzi C, De Cecco CN, Autore C, Cook EF, Hauser T, Gibson CM, Manning W, Appelbaum E, Maron M. Prognostic utility of contrastenhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: An international multicenter study. J Am Coll Cardiol. 2012;59(suppl A):A385. Abstract.
23. Morrow AG, Fogarty TJ, Hannah H 3rd, Braunwald E. Operative treatment in idiopathic hypertrophic subacute stenosis. Techniques and the results of preoperative and postoperative clinical and hemodynamic assessments. Circulation. 1968;37:589-596.
24. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232-2239. (Pubitemid 44789498)
25. Maron BJ. Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation. 2007;116: 196-206. (Pubitemid 47057526)
26. Maron BJ, Ommen SR, Nishimura RA, Dearani JA. Myths about surgical myectomy: Rumors of its death have been greatly exaggerated. Am J Cardiol. 2008;101:887-889.
27. Maron BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Gersh BJ, Nishimura RA. The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;44:2044-2053. (Pubitemid 39480744)
28. Nagueh SR, Groves BM, Schwartz L, Smith KM, Wang A. Bach RG, Nielsen C, Leya F, Buergler JM, Rowe SK, Woo A, Maldonado YM, Spencer WH 3rd. Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American Registry. J Am Coll Cardiol. 2011;58:2322-2328.
29. Iacovoni A, Spirito P, Simon C, Iascone M, Di Dedda G, De Filippo P, Pentiricci S, Boni L, Senni M, Gavazzi A, Ferrazzi P. A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy. Eur Heart J. 2012;33:2080-2087.
30. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ. Prevalence, clinical profile and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation. 2006;114:216-225. (Pubitemid 44297115)
31. Maron MS, Kalsmith BM, Udelson JE, Li W, DeNofrio D. Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy. Circ: Heart Fail. 2010;3:574-579.
32. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104: 2517-2524. (Pubitemid 33107372)
33. Di Donna P, Olivotto I, Delcrè SDL, Caponi D, Scaglione M, Nault I, Montefusco A, Girolami F, Cecchi F, Haissaguerre M, Gaita F. Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: Impact of age, atrial remodeling, and disease progression. Europace. 2010;12:347-355.
34. Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy: From bench to the clinics. J Cardiovasc Electrophysiol. 2008;19:104-110.